Don't forget the Cellprymes guys.
One makes drugs more effective, the other makes the environment for the drugs more effective.
They can both be enormous, and Thermo Fisher are thoroughly checking them out atm.
There is so much potential value in the Cellprymes and the market doesn't seem to see it, but big pharma does.
Ann: Continued promising results in PTX-100 TCL trial, page-39
Add to My Watchlist
What is My Watchlist?
